Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Bleeding in Patients with Clinically Severe Von Willebrand Disease: Preliminary Results of Athn 9, a Natural History Study of the Safety, Effectiveness, and Practice of Treatment for People with Severe Von Willebrand Disease (VWD)

Angela C. Weyand, MD, Kenneth D Friedman, MD, Sweta Gupta, MD, Kristina M. Haley, DO, Chunla He, Salley Pels, MD, Jonathan C. Roberts, MD, Crystal Watson, BS, Robert F. Sidonio, Jr., MD MSc.

Blood (2020) 136 (Supplement 1): 27–28.

https://doi.org/10.1182/blood-2020-137124

Published: 2020

Journal Articles

Genotype Analysis of Adolescents with Heavy Menstrual Bleeding and Low Von Willebrand Activity - Report of a Multi-Center Study

Brooke Sadler, PhD, Charles Minard, PhD, Gabe Haller, Christina Gurnett, Sarah H. O'Brien, MD, Allison P. Wheeler, MD, Eric S. Mullins, MD, Mukta Sharma, MD MPH, Robert F. Sidonio, Jr., MD MSc., Shilpa Jain, Ayesha Zia, MD, Margaret V. Ragni, MDMPH, Roshni Kulkarni, MD, Jennifer Dietrich, Peter A. Kouides, MD, Jorge Di Paola, Lakshmi Srivaths, MD

Blood (2020) 136 (Supplement 1): 19–20.

https://doi.org/10.1182/blood-2020-135886

Published: 2020

Journal Articles

Severe Bleeding Events in Hemophilia Α Patients Receiving Emicizumab Prophylaxis

Karen L. Zimowski, MD, Glaivy M. Batsuli, MD, Paulette Bryant, MD, Jenny McDaniel, MD, Kelly Tickle, MSN, APN, PPCNP-BC, Shannon L. Meeks, MD, Robert F. Sidonio, Jr., MD MSc

Blood (2019) 134 (Supplement_1): 1126.

https://doi.org/10.1182/blood-2019-126659

Published: 2019

Journal Articles

Thrombotic Outcomes Following Hormonal Treatment of Heavy Menstrual Bleeding in Pediatric Patients Taking Anticoagulation

Michael H. White, MD, Gary Woods, MD, Robert F. Sidonio, Jr., MD MSc

Blood (2019) 134 (Supplement_1): 2179.

https://doi.org/10.1182/blood-2019-130100

Published: 2019

Journal Articles

Spontaneous Bleeding and Poor Bleeding Response with Extended Half-Life Factor IX Products: A Survey of Select US and Canadian Hemophilia Treatment Centers

Lynn M Malec, MD, Stacy E. Croteau, Michael Callaghan, MD, Davide Matino, MD MSc, Kenneth Dale Friedman, MD, Robert F. Sidonio, Jr., MD MSc

Blood (2019) 134 (Supplement_1): 2407.

https://doi.org/10.1182/blood-2019-126196

Published: 2019

Journal Articles

Obtaining a Von Willebrand Evaluation at Time of Acute Heavy Menstrual Bleeding Presentation Leads to Overestimation of Von Willebrand Levels

Megan C. Brown, MD, Michael H. White, MD, Robert F. Sidonio, Jr., MD MSc

Blood (2019) 134 (Supplement_1): 627.

https://doi.org/10.1182/blood-2019-127258

Published: 2019

Journal Articles

The Discordance between Offsite to Onsite Testing for Von Willebrand Disease in Post-Menarchal Females: A Multi-Center Study

Julie Jaffray, MD, Robert F. Sidonio, Jr., MD MSc, Jemily Malvar, MS, Janice M Staber, MD, Kristina M. Haley, DO, Amy Stillings, Angela C. Weyand, MD, Sarah H. O'Brien, MD, Peter A. Kouides, MD

Blood (2019) 134 (Supplement_1): 628.

https://doi.org/10.1182/blood-2019-122379

Published: 2019

Journal Articles

Clinical Study to Investigate the Efficacy and Safety of Wilate during Prophylaxis in Previously Treated Patients with Von Willebrand Disease (VWD)

Robert F. Sidonio, Jr., MD MSc, Bruce A. Schwartz, PhD

Blood (2019) 134 (Supplement_1): 4931.

https://doi.org/10.1182/blood-2019-128339

Published: 2019

Journal Articles

Assessing the Safety of Various VWF Regimens in Patients with Clinically Severe VWD: A Natural History Study

Robert F. Sidonio, Jr., MD MSc, Angela C. Weyand, MD, Dunlei Cheng, PhD, Crystal Watson

Blood (2019) 134 (Supplement_1): 1132.

https://doi.org/10.1182/blood-2019-128318

Published: 2019

Journal Articles

Von Willebrand Disease Minimize Menorrhagia (VWDMin) Trial

Blood (2019) 134 (Supplement_1): 1130.

https://doi.org/10.1182/blood-2019-124234

Published: 2019

Journal Articles

Lack of Inhibitor Development in the American Thrombosis and Hemostasis Network (ATHN)-2 Factor Switching Study: Preliminary Report of Primary Outcome

Robert F. Sidonio, Jr., MD MSc, Dunlei Cheng, PhD, Christine Guelcher, PPCNP-BC, Janna M. Journeycake, MD, Susan U Lattimore, Clifford Takemoto, MD, Michael D. Tarantino, MD, Crystal Watson, Ellis J. Neufeld, MD, Carol Fedor, RN

Blood (2019) 134 (Supplement_1): 1114.

https://doi.org/10.1182/blood-2019-128612

Published: 2019

Journal Articles

Females With FVIII Deficiency Have Reduced Mean Overall Joint Range Of Motion

Robert F. Sidonio, Jr., MD, MSc, Fatima Mili, MD, PhD, Tengguo Li, PhD, Connie H. Miller, PhD, W Craig Hooper, PhD, Michael R. DeBaun, MD, MPH, J. Michael Soucie, Ph.D.

Blood (2013) 122 (21): 3601.

https://doi.org/10.1182/blood.V122.21.3601.3601

Published: 2013

Journal Articles

Discordance in Provider Practice Patterns and Hemophilia A Carrier Health Care Preferences

Allison Paroskie, MD, Olatunde Ooso, BS, Benjamin Almassi, Michael R. DeBaun, MD, MPH, Robert F Sidonio, Jr., MD, MSc

Blood (2012) 120 (21): 3385.

https://doi.org/10.1182/blood.V120.21.3385.3385

Published: 2012

Journal Articles

Retrospective Review of Hematologic Evaluation in Children with Suspected Non-Accidental Injury, A First Step towards Evidence Based Guidelines.

Allison Paroskie, MD, Shannon Carpenter, MD, MS, Deborah Lowen, MD, James Anderst, MD, MSC, Michael R. DeBaun, MD, MPH, Robert F Sidonio, Jr., MD, MSc

Blood (2012) 120 (21): 2231.

https://doi.org/10.1182/blood.V120.21.2231.2231

Published: 2012

NARROW

Bleeding in Patients with Clinically Severe Von Willebrand Disease: Preliminary Results of Athn 9, a Natural History Study of the Safety, Effectiveness, and Practice of Treatment for People with Severe Von Willebrand Disease (VWD)

Genotype Analysis of Adolescents with Heavy Menstrual Bleeding and Low Von Willebrand Activity - Report of a Multi-Center Study

Severe Bleeding Events in Hemophilia Α Patients Receiving Emicizumab Prophylaxis

Thrombotic Outcomes Following Hormonal Treatment of Heavy Menstrual Bleeding in Pediatric Patients Taking Anticoagulation

Spontaneous Bleeding and Poor Bleeding Response with Extended Half-Life Factor IX Products: A Survey of Select US and Canadian Hemophilia Treatment Centers

Obtaining a Von Willebrand Evaluation at Time of Acute Heavy Menstrual Bleeding Presentation Leads to Overestimation of Von Willebrand Levels

The Discordance between Offsite to Onsite Testing for Von Willebrand Disease in Post-Menarchal Females: A Multi-Center Study

Clinical Study to Investigate the Efficacy and Safety of Wilate during Prophylaxis in Previously Treated Patients with Von Willebrand Disease (VWD)

Assessing the Safety of Various VWF Regimens in Patients with Clinically Severe VWD: A Natural History Study

Von Willebrand Disease Minimize Menorrhagia (VWDMin) Trial

Lack of Inhibitor Development in the American Thrombosis and Hemostasis Network (ATHN)-2 Factor Switching Study: Preliminary Report of Primary Outcome

Females With FVIII Deficiency Have Reduced Mean Overall Joint Range Of Motion

Discordance in Provider Practice Patterns and Hemophilia A Carrier Health Care Preferences

Retrospective Review of Hematologic Evaluation in Children with Suspected Non-Accidental Injury, A First Step towards Evidence Based Guidelines.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only